Patrick McCall - Oct 4, 2024 Form 4 Insider Report for IN8BIO, INC. (INAB)

Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Oct 4, 2024
Transactions value $
$0
Form type
4
Date filed
10/8/2024, 04:15 PM
Previous filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +25.3K +94.62% 52.1K Oct 4, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Disposed to Issuer -20.5K -100% 0 Oct 4, 2024 Common Stock 20.5K $1.25 Direct F2, F3, F4
transaction INAB Series A Warrants (right to buy) Award +20.5K 20.5K Oct 4, 2024 Common Stock 20.5K $0.45 Direct F2, F3, F4
transaction INAB Series C Warrants (right to buy) Award +25.3K 25.3K Oct 4, 2024 Common Stock 25.3K $0.27 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.
F2 The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
F3 Fully vested and exercisable.
F4 The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.